Trial record 1 of 1 for:    nifurtimox and medulloblastoma
Previous Study | Return to List | Next Study

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by Spectrum Health Hospitals
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals Identifier:
First received: January 14, 2008
Last updated: October 7, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)